Jeff Ryckman
@jryckman3
Medical Physicist turned MD | Dedicated to LR-PFS 🎯, QoL, isotoxicity ⚖️, constraints 🙅‍♀️, & reproducibility 📊 | Creator of @RadOncReview | #RadOncCalc
ID: 85858016
https://radonccalc.radoncreview.org/ 28-10-2009 16:48:48
10,10K Tweet
4,4K Followers
3,3K Following
Beau Bosko Toskich, MD FSIR Mersiha Hadziahmetovic Yakup ErgĂĽn ACS Journal Cancer Completely agree! The key is selecting the best LC modality per patient through multiD decision-making. Dual IR/RO approaches are some of my favorite across any disease site. When total consolidation runs like a well-oiled machine & both hands work together, patients can achieve